NIH: Higher Buprenorphine Doses Associated With Improved Retention in Treatment for Opioid Use Disorder
September 19, 2023
September 19, 2023
WASHINGTON, Sept. 19 (TNSjou) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release on Sept 18, 2023:
* * *
NIH-funded study suggests need to reevaluate opioid addiction treatment recommendations in the era of fentanyl.
* * *
Individuals with opioid use disorder who were prescribed a lower buprenorphine dose were 20% more likely to discontinue treatment than those on a higher dose, . . .
* * *
NIH-funded study suggests need to reevaluate opioid addiction treatment recommendations in the era of fentanyl.
* * *
Individuals with opioid use disorder who were prescribed a lower buprenorphine dose were 20% more likely to discontinue treatment than those on a higher dose, . . .